Ovarian carcinoma: a multivariate analysis of prognostic factors
- PMID: 3969240
Ovarian carcinoma: a multivariate analysis of prognostic factors
Abstract
Five hundred and fifty six women with invasive epithelial ovarian carcinoma were assessed for postoperative treatment between 1966 and 1976. The records of this group were reviewed retrospectively. Sixteen characteristics of the patient and tumor were analyzed for prognostic significance by univariate and multivariate techniques. Tumor grade, the presence of residual disease, and patient performance status are identified as stage-specific independent prognostic factors. These independent factors define patient subsets with good, intermediate, and poor prognosis within each stage. The results show that more effective treatment strategies are required for patients in poor prognosis subsets. Estimates of tumor grade, extent of residual disease, and performance status should be included in reports of treatment outcome.
Similar articles
-
Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.Gynecol Oncol. 1999 Mar;72(3):278-87. doi: 10.1006/gyno.1998.5145. Gynecol Oncol. 1999. PMID: 10053096
-
The prognostic significance of peritoneal seeding and size of postsurgical residual in patients with stage III epithelial ovarian cancer treated with surgery, chemotherapy, and high-dose radiotherapy.Gynecol Oncol. 1999 Sep;74(3):400-7. doi: 10.1006/gyno.1999.5477. Gynecol Oncol. 1999. PMID: 10479500
-
Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.Clin Cancer Res. 1997 Jun;3(6):999-1007. Clin Cancer Res. 1997. PMID: 9815777
-
Prognostic factors in ovarian cancer.Semin Oncol. 1998 Jun;25(3):305-14. Semin Oncol. 1998. PMID: 9633842 Review.
-
Management of early-stage ovarian cancer.Hematol Oncol Clin North Am. 1992 Aug;6(4):867-77. Hematol Oncol Clin North Am. 1992. PMID: 1500390 Review.
Cited by
-
Fertility-sparing surgery and oncologic outcome among patients with early-stage ovarian cancer ~propensity score- matched analysis~.BMC Cancer. 2019 Dec 19;19(1):1235. doi: 10.1186/s12885-019-6432-4. BMC Cancer. 2019. PMID: 31856753 Free PMC article.
-
Outcomes of laparoscopic fertility-sparing surgery in clinically early-stage epithelial ovarian cancer.J Gynecol Oncol. 2016 Mar;27(2):e20. doi: 10.3802/jgo.2016.27.e20. J Gynecol Oncol. 2016. PMID: 26768783 Free PMC article.
-
Serous ovarian carcinoma patients with high alpha-folate receptor had reducing survival and cytotoxic chemo-response.Mol Oncol. 2012 Jun;6(3):360-9. doi: 10.1016/j.molonc.2011.11.010. Epub 2011 Dec 20. Mol Oncol. 2012. PMID: 22265591 Free PMC article.
-
Extent of apoptosis in ovarian serous carcinoma: relation to mitotic and proliferative indices, p53 expression, and survival.Mol Pathol. 1997 Oct;50(5):242-6. doi: 10.1136/mp.50.5.242. Mol Pathol. 1997. PMID: 9497913 Free PMC article.
-
Do patients with reduced or excellent performance status derive the same clinical benefit from novel systemic cancer therapies? A systematic review and meta-analysis.ESMO Open. 2017 Sep 21;2(4):e000225. doi: 10.1136/esmoopen-2017-000225. eCollection 2017. ESMO Open. 2017. PMID: 29209535 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical